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HeteroplasmyAbstract Background: Multiple studies have suggested that subjects with glutathione
S-transferase P1 (GSTP1)-mutations are at high risk for urinary bladder cancer (UBC).
Methods: In the present study, we evaluated the mutations in GSTP1 and mitochondrial
D-loop genes in two unrelated familial bladder cancer patients belonging to Karbi Anglong
Assam tribe. Mitochondrial D-loop and nuclear GSTP1 polymorphic region were amplified and
sequenced for all the family members and patients. Two SNPs in the GSTP1 gene for amino acid
substitutions at codons 105 (Ile?Val) and 114 (Val?Ala) were genotyped by PCR-RFLP-based
methods.
Results: mtDNA D-loop sequence variations were found and there were A and C insertions
common at positions 235 and 309, respectively for both the families. Two sequence differences
were identified in urinary bladder cancer samples in GSTP1 gene. These two heteroplasmic muta-
tions were found at positions 11qG3037G/A and 11qC3038C/A in patient, father, mother,
brother and son, but not in the sister and wife samples in family 2. The GSTP1, 105Ile > Val
is most susceptible to inherited UBC risk for these ethnic families. The samples from families
1 and 2, including healthy subjects were placed in macrohaplogroup L3e, except the wife (macro-
haplogroup F1c1a) of patient in family 1, and the wife and son (haplogroup M) of the patient in
family-2.
Conclusion: A strong familial nuclear GSTP1 sequence variation and mitochondrial control
region was observed in this study for familial urinary bladder cancer. This could afford earlyn Karbi-
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Anglong tribe of Assam, Northeast India, Erecognition of patients at risk of developing micro- or macroscopic, pathological lesions as well
as the introduction of preventive measures for familial bladder cancer.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bladder cancer is more common in men and women from
industrial areas and the incidence increases with exposure to
cigarette smoke and arylamines [1]. Men are affected more
often than women (3–4:1) and in most cases patients are over
the age of 50 years [2]. As per Indian cancer registry data, in
men, it is the ninth most common cancer accounting for
3.9% of all cancer [3]. Urothelial carcinoma comprises about
90% of all primary tumors of the urinary bladder [4].
Glutathione-S-transferases (GSTs) constitute a superfamily
of phase II enzymes that are involved in the detoxification of
various compounds such as xenobiotic, environmental sub-
stances, and potentially carcinogenic compounds [5,6]. Most
studies concentrate on the impact of GST, mainly GSTM1
and GSTT1, or on other polymorphic candidate genes for can-
cer detection [7]. An amino acid variation of isoleucine/valine
at codon position 105 in the protein was found due to the
GSTP1313 A/G polymorphism at the nucleotide level and
valine amino acid which leads to a reduced enzyme activity [8].
Fliss et al. [9] demonstrated somatic mutations of mtDNA
in bladder, head and neck, and lung cancers, mainly observed
in the D-loop region of mtDNA [10]. The mtDNA transcrip-
tion and replication are mainly regulated by the D-loop, and
alterations in this region might definitely change the rate of
mtDNA replication. This may be why a range of cancers com-
monly have mutations in the D-loop region. Therefore, we pre-
dict that variation in the mitochondrial control region might
also develop into a genetic marker of hereditary urinary blad-
der cancer. Jakupciak et al. demonstrated that mtDNA muta-
tions in the D-loop were also detected in urine precipitation
from bladder cancer patients [11]. Twenty-three of twenty-six
bladder cancer [88%] patients were found to have mtDNA
mutations in either the tumor or body fluid or in both [11].
The aim of the present study is to evaluate the presence of
mutations in GSTP1 and mitochondrial D-loop sequence of all
the family members of the two unrelated bladder cancer
patients from Karbi-Anglong tribes of Assam, India
2. Subjects and methods
2.1. Sample collection and processing
Ethnically, the Karbis belong to the Mongoloid tribe and lin-
guistically to the Tibeto-Burman group. In the current study, a
Karbi-Anglong family in which at least two first-degree rela-
tives had urinary bladder cancer and another family in which
two cases were pathologically diagnosed in second-degree rel-
atives were identified from District Hospital, Dimapur, Naga-
land, India (Fig. 1A). Ten members were recruited from family
1 to 9 members from family 2 including the urinary bladder
cancer patients. Two healthy subjects from the same ethnic
tribes were also included as controls. The protocol of our study
was approved by the Institutional Review Board of all insti-t al., Mitochondrial control region and
gypt J Med Hum Genet (2016), http://dtutes involved in the study. The work has been carried out in
accordance with the Code of Ethics of the World Medical
Association (Declaration of Helsinki) for doing the research
work with human samples.
2.2. Selection criteria
Clinical Practice Points about the cases are as follows:
 Family 1
Patient having hematuria: Tumor was removed from the
bladder through the urethra by transurethral resection
(TURBT). Tumor was non-invasive type. A low-grade
superficial papillary carcinoma (Ta) was found in the blad-
der. Tumor was found on a small section of tissue that was
easily removed with TURBT. Patient has a cigarette smok-
ing habit.
 Family 2
Patient having hematuria: Tumor was removed from the
bladder through the urethra by transurethral resection
(TURBT). Tumor was invasive type. High-grade superficial
T1 tumors are found in the bladder (lamina propria carci-
noma). The tumor has spread to the subepithelial connec-
tive tissue but does not involve the bladder wall muscle.
Patient has a cigarette smoking habit.2.3. DNA extraction and PCR amplification
Genomic DNA was isolated from 200 ll of each blood sample
using the protocol of Ghatak et al. [12]. D-loop region of mito-
chondrial DNA was amplified by PCR using primers HMt-F
(50-CACCATTAGCACCCAAAGCT-30) and HMt-R (50-CT
GTTAAAAGTGCATACCGCCA-30) for HVI region [13].
PCR (vapo.protect; Eppendorf) was carried out in 25 ll total
reaction volume, each containing 100 ng template DNA,
0.2 pM of each primer, 2.5 ll 10 PCR buffer (final 1
PCR buffer), 1.5 mM MgCl2, 200 mM dNTP, and 1 unit
Taq DNA polymerase. The reaction mixture was heated to
94 C for 5 min, followed by 40 cycles, each consisting of
1 min denaturation at 94 C, 1 min annealing at 63 C, 90 s
extension at 72 C, and a final 10-min extension at 72 C.
GSTP1 polymorphism study was performed with the primers
(F-50-ACAGGATTTGGTACTAGCCT-30; R-50-AGTGCCT
TCACATAGTCATCCTTG-30) for intron 5–6 and exon 6
amplification [14]. PCR cycling conditions were 5 min at
94 C followed by 35 cycles of 94 C for 30 s, 50 C for 30 s
and 72 C for 30 s with a final elongation step at 72 C for
7 min. The PCR amplification products (10 ll) were subjected
to electrophoresis (Bio-Rad) on 1.2% agarose gel in
Trisacetate-EDTA buffer at 80 V for 30 min and stained with
ethidium bromide (Himedia), and images were obtained in gel
documentation (G-Box; Syngene, Cambridge, UK) systems.
PCR products were sequenced by Sanger sequencing method
in Scigenom, Cochin, India.GSTP1 polymorphism associated with familial urinary bladder cancer in Karbi-
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Figure 1 (A) Pedigree chart for family-1 and family-2, (B) GSTP1 heteroplasmic mutation in the familial urinary bladder cancer
(11qG3037G/A and 11qC3038C/A) in family 2.
Novel mutation in urinary bladder cancer 32.4. GSTP1 polymorphic site identification by RFLP
In addition, two SNPs in the GSTP1 gene for amino acid sub-
stitutions at codons 105 (Ile?Val) [8] and 114 (Val?Ala) [14]
were genotyped by PCR-RFLP-based methods. The fragment
containing the GSTP1 Ile105Val (rs1695) polymorphic site was
amplified: 94 C for 5 min followed by 35 cycles of 94 C for
30 s, 58 C for 30 s, 72 C for 1 min and a final elongation at
72 C for 7 min. About 10 ll of each PCR product was
digested with 1 unit of BsmAI (New England Biolabs, Spain)
for 6 h at 55 C. Digests were then electrophoresed on 8%
polyacrylamide gel resulting in three fragments of 305, 135
and 128 bp (for allele A) or in four fragments of 222, 135,
128 and 83 bp (for allele G). For studying the GSTP1
Val114Ala (rs1138272) polymorphism, PCR cycling conditions
were 5 min at 94 C followed by 35 cycles of 94 C for 30 s,
52 C for 30 s and 72 C for 30 s with a final elongation step
at 72 C for 7 min. 10 ll of PCR product was digested with 1
unit of AciI (New England Biolabs, Spain) for 6 h at 37 C
and electrophoresed on a 8% polyacrylamide gel. The T allele
was defined by the presence of an intact fragment of 170 bpPlease cite this article in press as: Ghatak S et al., Mitochondrial control region and
Anglong tribe of Assam, Northeast India, Egypt J Med Hum Genet (2016), http://dand the C allele by the presence of two fragments of 143 and
27 bp.
2.5. Sequence analysis
All PCR products were sequenced from the opposite direction
to ensure reading accuracy. Sequences and chromatograms
obtained were examined using chromas software version 2.13
and aligned by BLAST (http://www.ncbi.nlm.nih.gov/blast).
All sequences were compared with the latest version of Revised
Cambridge Reference Sequence (rCRS) of the human mito-
chondrial DNA (NC_012920) and subsequently analyzed for
the variation in sequences using Mito Tool Programming.
The results of the DNA sequence analysis were compared with
the published Cambridge Sequence using Mutation Surveyor
version 1.4 DNA mutation analysis software (Softgenetics,
State College, PA). Sequence differences between patients
and healthy blood samples were recorded as mtDNA polymor-
phisms. Each polymorphism was then verified against the Mit-
omap database (http://www.mitomap.org/) and further
classified as novel or reported, depending on whether or notGSTP1 polymorphism associated with familial urinary bladder cancer in Karbi-
x.doi.org/10.1016/j.ejmhg.2016.02.002
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were used for the mitochondrial haplotypes estimation using
Haplogrep server to detect mitochondrial DNA profiles based
on Phylotree build 16. The estimated haplogroups were veri-
fied using manual checking of Phylotree build 16 from www.
Phylotree.org database. The GSTP1 gene sequence were ana-
lyzed by the mutation surveyor and ensemble genome browser
for polymorphism identification.
3. Results
PCR resulted in a successful amplification of 1030 and 190 bp
bands from the D-loop and GSTP1 genes, respectively. All the
familial samples with healthy Karbi tribe were placed in
macrohaplogroup L3e, except for the wife of patient who
was placed in macro-haplogroup F1c1a for family-1 and wife
and son (major-haplogroups M) for family-2 (Table 1).
A total of 5 mtDNA D-loop sequence variations at 5 dis-
tinct nucleotide positions were found in patient, mother and
sister samples in family 1, and 3 distinct variations in family
2. Insertions were found in positions 235 (intA) and 309 (intC)
in both the families (Table 2). Among these variations, 2 inser-
tions, 1 small deletion, 1 short sequence repeat and 1 base sub-
stitution were observed in the case of family-1. The sequence
variations were mostly transitional substitutions except for a
cytosine copy number change (7C/8C) at np 303–309 (Table 2).
The mutations were mostly not reported in the literature or the
public mtDNA mutation databases (Table 2).
Two nucleotide base differences were identified at GSTP1-
intron 5–6 position in all the members of family 2 in contrastTable 1 Haplogroup information based on the mitochondrial D-lo
Family-1 Famil
Sample ID Sample Age (yrs) Haplogroup Sampl
NMD1 Mother (index person) 67 L3e NGF1
NFD1 Father 71 L3e NMD
NPD1 Son (target patient) 46 L3e NFD1
NBD1
(2 no.)
Brother (1 is patient) 49 L3e NPD1
44
NSD1
(2 no.)
Sister 41 L3e NBD1
(2 no.
NWD1 Wife 41 F1c1a NWD
NDD1 Daughter 12 L3e NDS1
(2 no.NDS1 Son 14 L3e
NN1D1 Healthy control 52 L3e NN1D
NN1D1 Healthy control 49 L3e NN1D
Table 2 Mitochondrial D-loop mutations in the cancer patients.
Family-1 F
Position Sample Reference
nucleotide
Nomenclature of the
mutation
P
202y Sister – 202A-Int 2
235y Patient – 235A-Int
309 Mother and
patient
– 310C-Int 3
337y Patient A 337A-Del 3
384y Patients A 384A > C
y Indicates novel mutations (not reported in the Mitomap database).
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tions were found at positions 11qG3037G/A and 11qC3038C/
A in patient, father, mother, brother and son samples, but
absent in the case of sister and wife samples for family 2. Sig-
nificant differences in genotype or allele frequencies of the
GSTP1 IIe105Val polymorphisms were observed in family 2
(Fig. 1A) but not in family 1. The presence of heterozygous
allele A/G in rs1695 was found in maternal DNA as an index
person, and homozygous allele G/G in rs1995 was found in the
patient in family 2 (Fig. 1A). In case of rs1138272, C/C
homozygous was observed for both the family members.
4. Discussion
Our sequence analysis focused on the mtDNA D-loop region
which is highly polymorphic and contains two hypervariable
regions, HV1 (16024–16383) and HV2 (57–333), that are con-
sidered as somatic mutation ‘‘hot spot” regions in many types
of cancer [15]. In this study, no deletions were seen in the mito-
chondrial genome. A total of 5 mtDNA D-loop sequence vari-
ations at 5 distinct nucleotide positions were found in patient,
mother and sister samples out of the all samples examined for
family 1, which were not previously reported. Fliss et al.
screened 14 urinary bladder cancers for somatic mutations in
the D-loop region and found mutations in 4 (29%) samples [9].
The mononucleotide repeats at nucleotide position 303–309
represent a well known mutational hotspot prone to instability;
the instability at this position were found in mother and patient
samples for family 1. Marchington et al. [16] first used the term
D310 to describe a highly polymorphic mononucleotide tract ofop gene.
y-2
e ID Sample Age (yrs) Haplogroup
Grandfather (index person) Deceased at 74 L3e
1 Mother 65 L3e
Father (index person) 67 L3e
Son (target Patient) 42 L3e
)
Brother 46 L3e
38
1 Wife 39 M
)
Son 14 M
10
1 Healthy control 52 L3e
1 Healthy control 49 L3e
amily-2
osition Sample Reference
nucleotide
Nomenclature of the
mutation
35y Patient – 235A-Int
09 Father and
patient
– 310C-Int
84y Patients A 384A > C
GSTP1 polymorphism associated with familial urinary bladder cancer in Karbi-
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Novel mutation in urinary bladder cancer 5poly (C) that varies from 12 to 18 Cs, located between nucleo-
tide positions 303 and 318 in CSB II, that forms a RNA–DNA
hybrid known as an R-loop. This poly (C) region is interrupted
at nucleotide position 310 by a T (CCCCCCCTCCCCC), in
which the number of Cs before the T can varies between 7
and 9 in normal polymorphic variants [17]. The sequence vari-
ations in D-loop region were mostly transitional substitutions
except for a cytosine copy number change (7C/8C) at np 303–
309 (Table 2) which was found in both the families. Wada
et al. [18] also reported that the majority of somatic mutations
were homoplasmic suggesting that the mutant mtDNA became
dominant in tumor cells. Hence, a strong maternal mutational
inheritance was observed in this study.
A strong familial nuclear GSTP1 sequence variation was
observed in this study for urinary bladder cancer in family 2.
Although the risk is modest, the high prevalence of deficiency
is likely to make a significant impact on bladder cancer inci-
dence [19]. To¨ru¨ner et al. [20] reported that GSTP1Ile/Val or
Val/Val genotype enhanced the vulnerability to bladder cancer
by 1.75-folds. In a different study, Srivastava et al. [21]
reported that the Val/Val genotype of the GSTP1 gene poly-
morphism increases the susceptibility by 7.1-fold. In the
GSTpi-1 gene, GSTP1 105 (rs1695) polymorphism evaluated
was related to familial urinary UBC susceptibility or pheno-
type. The homozygous status of GSTP1 105 (rs1695)
(A > 105G) is most susceptible to UBC risk in Karbi-
Anglong tribe of Assam, Northeast India, but familial
heterozygous (A/G) is also a risk factor for UBC. Two hetero-
plasmic mutations were found at positions 11qG3037G/A and
11qC3038C/A in family-1. These two heteroplasmic mutations
might be the potential factors for inherited familial UBC. In
Caucasians, complete lack of GSTM1 activity was observed
in 50% of the population. About 1.47-fold increase in bladder
cancer risk is associated with GSTM1 deficiency and GSTT1
mutation in one fifth of cases [22]. Inheritance of the GSTT1
null genotype was found to be associated with several types
of carcinogenesis including bladder cancer [23]. Indeed, the
GSTP1codon 105Val allele was associated with a significantly
increased risk of lung, bladder, and testicular cancers [23].5. Conclusion
To our knowledge, the present study is a novel finding in-terms
of the possible role of mtDNA D-loop and nuclear GSTP1
gene mutations in familial urinary bladder cancer in Assam
Karbi tribe population. The impact of this novel finding for
clinical practice in the foreseeable future is that the mitochon-
drial D-loop gene and nuclear GST alterations may attribute
to familial urinary bladder cancer in Assam Karbi population.Conflict of interest
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